JPRN-jRCTs032180046已完成1 期
Evaluation of the utility of cardio-pulse wave examination device for the atherosclerosis disease - CPWE study
Matsumura Akira0 个研究点目标入组 50 人开始时间: 2018年11月29日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
o adverse events related to the device were observed, and this study protocol was safe to perform. We believe that the research data and know-how obtained in this study will be useful for the development and improvement of cardio-pulse wave examination device. In addition, it is useful data for selecting patients who are effective in using this device, how to use them, and interpreting the results.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients satisfying all of the following criteria are subject to this clinical trial.
- •1. Patients with arteriosclerotic diseases of cerebral artery / carotid arteriosclerosis, coronary arteriosclerosis, and arteriosclerosis obliterans.
- •2. Patients clinically diagnosed with arteriosclerosis by image inspection such as blood pressure, blood test, echo, CT, MRI, etc., or patients suspected.
- •3. Patient who can consent document by himself / herself. If writing is difficult due to hemiplegia or the like, put a substitute writer. If consent by the person himself / herself is difficult due to aphasia or the like, put a substitute person.
- •4. Patient who is over 20 years of age at consent acquisition.
排除标准
- •Patients who conflict with one of the following criteria are excluded and not subject to this clinical study.
- •1. Patients who cannot wear device due to amputation of both lower leg.
- •2. Patients using active implantable medical devices such as cardiac pacemakers.
- •3. Patients who judged that medical doctor is inappropriate for participation in this study.
- •4. Patients with severe consciousness disturbance.
- •5. Diseases and postoperative patients who may have an adverse effect on the evaluation of this device such as circulatory insufficiency such as shock, chronic atrial fibrillation, vasculitis, artificial blood vessel replacement surgery, stent graft interpolation, etc.
研究者
相似试验
已完成
不适用
3-Dimensional Mapping System: The PULSTAR StudyParoxysmal Atrial FibrillationNCT05618340Shanghai Shangyang Medical Technology Co., Ltd.149
Unknown
不适用
The Clinical Research of the Safety and Effectiveness Evaluation for Using Echocardiography-guided Liwen RF Radiofrequency Ablation System to Treat Hypertrophic Obstructive CardiomyopathyHypertrophic Obstructive CardiomyopathyNCT04355260Xijing Hospital150
已完成
1 期
Phase 1 Safety and Pharmacokinetic Study of AI-700 in Patients With Diminished DLCO and COPD and/or CHFCongestive Heart FailureChronic Obstructive Pulmonary DiseaseNCT00156780Acusphere
已完成
不适用
A Study of Intracardiac Ultrasound With the NUVISION NAV Ultrasound CatheterScar-related Atrial TachycardiaPremature Ventricular ComplexVentricular TachycardiaPersistent Atrial FibrillationParoxysmal Atrial FibrillationNCT05970120Biosense Webster, Inc.30
撤回
不适用
Exploratory Safety and Effectiveness Evaluation of Pulsed Field Ablation (PFA) by Balloon Catheter With TRUPULSE Generator for Treatment of Paroxysmal Atrial Fibrillation (PAF)Atrial FibrillationNCT06495216Biosense Webster, Inc.30